Infuse lawsuit: Judge orders Medtronic to produce safety data on bone growth protein

By

 
Infuse lawsuit: Judge orders Medtronic to produce safety data on bone growth protein

A federal judge in Minnesota orders Medtronic to produce documents detailing the safety profile of its controversial Infuse bone growth protein in a shareholders' lawsuit against the world's largest pure-play device maker.

A federal judge ordered Medtronic Inc. (NYSE:MDT) to produce documents detailing the safety record of its controversial Infuse bone growth protein.
The shareholders' lawsuit accuses the firm of artificially inflating its stock price with an off-label promotion scheme for a bone...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.